The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activity (Q45394300)
Jump to navigation
Jump to search
scientific article published on 19 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activity |
scientific article published on 19 June 2008 |
Statements
1 reference
The pharmacokinetics of silymarin is altered in patients with hepatitis C virus and nonalcoholic Fatty liver disease and correlates with plasma caspase-3/7 activity (English)
1 reference
1 reference
Angela D M Kashuba
1 reference
Sarah J Schrieber
1 reference
Zhiming Wen
1 reference
Manoli Vourvahis
1 reference
Philip C Smith
1 reference
Michael W Fried
1 reference
Roy L Hawke
1 reference
19 June 2008
1 reference
1 reference
Identifiers
1 reference